NCT02455856View on ClinicalTrials.gov

Study to Investigate Effects of Repeated Administration of Itraconazole on Pharmacokinetics of JNJ-42847922 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 18, 2015

Primary Completion Date

June 19, 2015

Study Completion Date

June 19, 2015

Conditions
Healthy
Interventions
DRUG

JNJ-42847922

Participants will receive single dose of 5 milligram (mg) JNJ-42847922 as 5 mg/milliliter \[mL\] oral solution on Day 1 and Day 6.

DRUG

Itraconazole

Participants will receive single dose of itraconazole as 200 mg (2\*100 mg capsule) from Day 2 to Day 6.

Trial Locations (1)

Unknown

Berlin

All Listed Sponsors
lead

Janssen Cilag N.V./S.A.

INDUSTRY

NCT02455856 - Study to Investigate Effects of Repeated Administration of Itraconazole on Pharmacokinetics of JNJ-42847922 in Healthy Male Participants | Biotech Hunter | Biotech Hunter